Below is the current list of 100 free pharmacology thesis topics for MD and DNB candidates. Each title uses a prescription-based, pharmacovigilance, questionnaire-based, record-based or comparative design that a postgraduate department can complete from the prescriptions and case records already passing through its own hospital, without prospective follow-up. Every topic generates a complete pharmacology protocol and pharmacology synopsis in editable format. For more topics you can avail the service of premium Pharmacology thesis topics.
Last reviewed and updated: August 2026
📌 Updated for 2026–2027 MD Pharmacology admissions
This pharmacology thesis topic list is updated for the 2026–27 academic cycle. Topics are reviewed against recent dissertations, examiner preferences, feasibility in Indian medical colleges, and publication trends in the field of pharmacology.
Select Generate Protocol → beside any title and receive a submission-ready document built around that topic, containing all eighteen components:
Subscribing to the premium thesis topics not only lets you browse the full premium list, it also gives you online guidance (guidance doesnt mean complete protocol) on synopsis writing, sample size calculation, inclusion and exclusion criteria, and support throughout thesis writing. If you do not subscribe, please still feel free to contact me for guidance.
Unlock Premium Pharmacology Topics 🔒Studying outside India?
The topics above work as research questions anywhere — what changes is the document your institution expects. Two different routes, depending on which applies to you.
PhD and Master's candidates — Saudi Arabia, Malaysia, the Gulf and beyond
University graduate programmes in Pharmacology and the basic medical sciences generally require a full research proposal of roughly 6,000 to 10,000 words, with an extended literature review, a theoretical framework and a detailed methodology chapter — considerably longer and deeper than a residency proposal. These are written individually, by a medical doctor, with no artificial intelligence generation and no plagiarism, and revised until your supervisor accepts them.
Enquire about a PhD research proposal →Board residents — SCFHS, Arab Board, OMSB, KIMS, QCHP, NHRA, DHA and DOH
In Gulf training programmes the equivalent of an Indian synopsis is the research proposal submitted to your IRB before a research project begins. The format differs from the Indian one: it additionally requires a Gantt chart, a budget and resources section, and a Declaration of Helsinki statement.
Generate a residency research proposal →🔥 Trending research areas in Pharmacology for 2026–27
Based on recent thesis submissions and examiner preferences in MD Pharmacology departments across India, these are the emerging high-interest areas:
A pharmacology protocol is judged on internal consistency: the research question, objectives, methodology and statistical plan must all describe the same study. The primary objective should be a single measurable endpoint — one prescribing indicator, one pattern, one comparison — with everything else demoted to secondary objectives.
The methodology must name the instrument or standard against which prescriptions will be judged, because almost every pharmacology dissertation rests on one. State whether you will apply the World Health Organization core prescribing indicators, the Anatomical Therapeutic Chemical classification with defined daily doses, the National List of Essential Medicines, an institutional or national standard treatment guideline, a named screening tool for inappropriate prescribing in the elderly, a named interaction-checking database, or the Naranjo scale and World Health Organization Uppsala Monitoring Centre criteria for causality with the Hartwig and Siegel scale for severity. Give the version and year of whichever you use, since these are revised and an examiner will ask which edition was applied.
Define the sampling frame precisely: which outpatient departments or wards, which days of the week, how prescriptions will be selected, and over what period. Inclusion and exclusion criteria are written for prescriptions or records, not patients — exclude illegible prescriptions, incomplete records, and repeat visits by the same patient where each encounter would otherwise be counted twice. Where a questionnaire is used, name the validated instrument or describe how a study-specific one was developed, pilot-tested and validated.
A pharmacology synopsis is the condensed document of two to four pages — title, introduction, aim and objectives, brief methodology, sample size and references — submitted for registration of the dissertation topic. The pharmacology protocol is the expanded version of twelve to twenty pages carrying the full review of literature, detailed methodology including the assessment tools and their versions, statistical plan, study timeline and annexures including the information sheet, consent form and data collection proforma.
In practice the synopsis is extracted from the protocol rather than written separately, which is faster and produces a more coherent document. Check your university's prescribed proforma before submission, since rejections on formatting grounds are common and entirely avoidable.
Most pharmacology dissertations estimate a proportion — the percentage of prescriptions containing an antimicrobial, the prevalence of polypharmacy, the proportion of encounters with a potential interaction — so a proportion-based calculation is expected, using the figure reported in a comparable published study, the desired absolute precision and the confidence level, with the source cited. Where two groups are compared, the calculation rests on the difference in proportions you consider meaningful. Note that the World Health Organization prescribing indicator methodology suggests a minimum of six hundred encounters for a facility-level assessment, and committees familiar with that figure will expect it to be addressed where those indicators are used.
Name the tests rather than promising that data will be analysed. Descriptive work reports frequencies and percentages with confidence intervals, and prescribing indicators are reported as means with standard deviations. Comparison of proportions between departments, sexes or facility types uses the chi-squared test, with Fisher's exact test for small cells. Comparison of the average number of drugs per encounter uses the independent t-test or the Mann-Whitney U test, with a stated normality test deciding between them, and comparison across three or more departments calls for analysis of variance. Association between the number of prescribed medicines and the number of potential interactions uses the Spearman coefficient, and where two assessors independently rate causality or appropriateness, report inter-rater agreement using a kappa statistic.
Start with access rather than interest. Prescription-based and record-based studies depend entirely on a clinical department agreeing to let you collect from their outpatient queue or case files, so establish which departments your guide already has a working relationship with before shortlisting. A polypharmacy study in geriatrics is not viable if that department will not cooperate.
Then check volume and completeness. Count how many prescriptions a chosen outpatient department generates on a study day, and inspect a sample for legibility and completeness. Finally, confirm the gap: prescription pattern studies are among the most published designs in Indian pharmacology, so your question needs an angle that comparable centres have not already reported.
Cross-sectional prescription-based drug utilisation studies account for the largest share of accepted pharmacology dissertations, followed by prescription audits against a defined standard, pharmacovigilance studies profiling reported adverse drug reactions, and questionnaire-based knowledge, attitude and practice studies among prescribers, students or patients.
Comparative designs contrasting two departments, two facility types or two patient groups are equally well established. Clinical trials are generally not feasible at postgraduate level in a non-clinical department, and designs requiring prospective follow-up seldom fit within the available time.
Bring three to five shortlisted titles rather than one, since guides frequently rule out a topic on grounds you could not have known — an ongoing departmental study, a clinical department that has declined access before, a pharmacovigilance database with too few reports to analyse.
Settle four things in that meeting: which clinical departments will grant access and who will write to them, which assessment tool or guideline you will judge prescriptions against, whether a second assessor is available for causality or appropriateness ratings, and which journal the eventual paper is aimed at.
Yes, and almost all of them are. Drug utilisation studies, prescription audits, pharmacovigilance analyses, drug interaction assessments, pharmacoeconomic cost comparisons and questionnaire-based studies all avoid interventional design entirely, need no drug administration, and are routinely accepted by Indian universities. Every topic listed above falls into these categories.
The synopsis is the condensed two to four page document submitted for topic registration. The protocol is the full document of twelve to twenty pages containing the detailed review of literature, methodology with the assessment tools and their versions, statistical plan, timeline and annexures. The synopsis is normally extracted from the completed protocol.
Institutional ethics committee approval is required before data collection even where no patient is approached. Studies analysing existing prescriptions or case records may be granted a waiver of consent, but this must be applied for explicitly, with the protocol setting out how prescriptions will be anonymised, where data will be stored and who will have access. Where patients are interviewed, inhaler technique is observed, or a questionnaire is administered, full written informed consent is required. Studies recruiting resident doctors or students should state how voluntariness is protected given the hierarchy involved. Clearance commonly takes six to ten weeks and retrospective approval is not granted.
Yes, and it is the step most often left until too late. Written permission from the head of each clinical department, and usually from the medical superintendent, is needed before you can collect prescriptions or access case records. Name the departments in the protocol and state who will obtain permission. Where the study uses pharmacovigilance data, permission from the coordinator of the adverse drug reaction monitoring centre is also required, and it is worth confirming in advance how many reports the database actually holds for your period of interest.
Substantially. A PhD proposal in pharmacology typically runs 6,000 to 10,000 words and carries an extended critical literature review, a theoretical framework, a detailed methodology chapter and a discussion of expected contribution to the field. An MD synopsis is a two to four page registration document. The research question can be the same; the depth expected is not.
Most universities require registration within six to nine months of joining. Shortlist in the first two months, finalise with your guide by the third, and file for ethics clearance and departmental permissions immediately afterwards, since permission from clinical departments can take as long as ethics clearance itself.
Found a topic that fits your department?
Generate its full protocol — objectives, methodology, sample size, statistics, timeline, references and annexures — in editable format.
Generate your protocol
